Case of benralizumab‐induced exacerbations of chronic spontaneous urticaria-Reference-Cited by-同舟云学术

Case of benralizumab‐induced exacerbations of chronic spontaneous urticaria

Published:2022-06 Issue:6 Volume:10 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clinical Case Reports

Author:

Magen Eli¹²^ORCID,Komarova Irina¹,Magen Israel³,Phirtskhalava Sofia³

Affiliation:

1. Department of Medicine C, Clinical Immunology and Allergy Division Barzilai University Medical Center Ben‐Gurion University of the Negev Ashkelon Israel

2. Leumit Health Services Tel Aviv‐Yafo Israel

3. Tbilisi State Medical University Tbilisi Georgia

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.5930

Reference16 articles.

1. Treatment of chronic spontaneous urticaria with benralizumab: Report of primary endpoint per‐protocol analysis and exploratory endpoints

2. Chronic idiopathic urticaria: infiltrating cells and related cytokines in autologous serum-induced wheals

3. Benralizumab for Chronic Spontaneous Urticaria

4. Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma

5. Hypersensitivity and adverse reactions to biologics for asthma and allergic diseases

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insight into IL-5 as a Potential Target for the Treatment of Allergic Diseases;Biomedicines;2024-07-10

2. Effets indésirables des biothérapies de l’asthme sévère;Revue des Maladies Respiratoires;2024-05

3. Comment on case of benralizumab‐induced exacerbations of chronic spontaneous urticaria;Clinical Case Reports;2024-04

4. A case of paradoxical eosinophilic fasciitis in a patient on benralizumab;JAAD Case Reports;2023-10

5. Basophil Characteristics as a Marker of the Pathogenesis of Chronic Spontaneous Urticaria in Relation to the Coagulation and Complement Systems;International Journal of Molecular Sciences;2023-06-19